Prostate Cancer
📧 Sign up to get email alerts when something new happens for Prostate Cancer.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2024-08-02FDA Approved: ERLEADA — Supplemental Application (Janssen Products, LP)
FDA approved a supplemental application for Erleada (apalutamide) submitted by Janssen Products, LP. The supplemental submission is related …
-
CLINICAL_TRIALS trial_result · 2024-08-02Clinical Trial Update: Safety of SGI-1776, A PIM Kinase Inhibitor in Refractory Prostate Cancer and Relapsed/Refractory Non Hodgkin's Lymphoma [Phase 1]
Phase 1 trial of SGI-1776, a PIM kinase inhibitor, in refractory prostate cancer and relapsed/refractory non-Hodgkin lymphoma was terminated…
-
CLINICAL_TRIALS trial_result · 2024-08-02Clinical Trial Update: A Study of HSP90 Inhibitor AT13387 Alone or in Combination With Abiraterone Acetate [Phase 1, Phase 2]
A Phase 1/2 study evaluating the HSP90 inhibitor AT13387 alone or in combination with abiraterone acetate for prostate cancer has completed.
-
CLINICAL_TRIALS trial_result · 2024-08-02Clinical Trial Update: Hypotension Prediction Index (HPI) in Patients Undergoing Robotic Assisted Radical Prostatectomy [NA]
Clinical trial update reporting the completion of a study evaluating the Hypotension Prediction Index (HPI) for preventing intraoperative hy…
-
CLINICAL_TRIALS trial_result · 2024-08-01Clinical Trial Update: Luteinizing Hormone-releasing Hormone Analogue and Enzalutamide +/- Zoledronic Acid in Prostate Cancer Patients [Phase 2]
This document reports a Phase 2 clinical trial evaluating a luteinizing hormone-releasing hormone analogue in combination with enzalutamide,…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
EMA approval · 2024-07-31EMA Authorised: Taxotere (docetaxel) — Sanofi Winthrop Industrie
The EMA authorised Taxotere (docetaxel) for multiple cancer indications including head and neck cancer, non-small cell lung cancer, gastric …
-
CLINICAL_TRIALS trial_result · 2024-07-31Clinical Trial Update: Multiparametric Assessment of Bone Response in mCRPC Patients Treated With Cabozantinib [Phase 2]
Phase 2 clinical trial update assessing bone response in metastatic castration-resistant prostate cancer patients treated with cabozantinib.
-
CLINICAL_TRIALS trial_result · 2024-07-31Clinical Trial Update: pCHIP: Prostate Cancer Health Impact Program
The Prostate Cancer Health Impact Program (pCHIP) trial, sponsored by Weill Medical College of Cornell University, has been terminated.
-
CLINICAL_TRIALS trial_result · 2024-07-29Clinical Trial Update: Transpelvic Magnetic Stimulation to Improve Urogenital Function [NA]
Completed clinical trial evaluating transpelvic magnetic stimulation to improve urogenital function in individuals with prostate cancer and …
-
CLINICAL_TRIALS trial_result · 2024-07-29Clinical Trial Update: Multispectral Fluorescence as a Tool to Separate Healthy and Disease Related Lymphatic Anatomies in Prostate Cancer.
This clinical trial update reports completion of a study evaluating multispectral fluorescence imaging to separate healthy lymphatics from d…
-
CLINICAL_TRIALS research · 2024-07-26Clinical Trial Update: LEARN: Learning Environment for Artificial Intelligence in Radiotherapy New Technology
The LEARN trial by the University of Sydney is evaluating a new AI-based radiotherapy environment and is currently recruiting across several…
-
CLINICAL_TRIALS research · 2024-07-24Clinical Trial Update: Two-Fraction Ultrahypofractionated Radiotherapy With Focal Boost for Intermediate Risk, Localized Prostate Cancer [NA]
Clinical trial evaluating two-fraction ultrahypofractionated radiotherapy with a focal boost for intermediate-risk localized prostate cancer…
-
CLINICAL_TRIALS trial_result · 2024-07-23Clinical Trial Update: Teverelix Evaluated in Advanced Prostate Cancer [Phase 2]
Antev Ltd. reports Phase 2 results update for Teverelix in advanced prostate cancer, with results posted on July 23, 2024.
-
CLINICAL_TRIALS research · 2024-07-23Clinical Trial Update: Evaluation of Perilesional Biopsy in Diagnosis of Prostate Cancer [NA]
This clinical trial update describes evaluating perilesional biopsy as a diagnostic approach for prostate cancer. The study at Peking Univer…
-
CLINICAL_TRIALS research · 2024-07-23Clinical Trial Update: Technologies to Improve QoL of Prostate Cancer [NA]
A clinical trial registry entry describes technologies intended to improve quality of life for prostate cancer patients. The study is curren…
-
CLINICAL_TRIALS trial_result · 2024-07-22Clinical Trial Update: A Study of Nivolumab or Placebo in Combination With Docetaxel in Men With Advanced Castration-resistant Prostate Cancer [Phase 3]
Phase 3 study evaluating nivolumab plus docetaxel versus placebo plus docetaxel in men with advanced castration-resistant prostate cancer ha…
-
CLINICAL_TRIALS trial_result · 2024-07-19Clinical Trial Update: Comparison of the Effectiveness of Supervised, Video-based and Home-based Resistance Exercise Program in Patients With Prostate Cancer [NA]
This clinical trial update reports on a completed study comparing supervised, video-based, and home-based resistance exercise programs in pa…
-
CLINICAL_TRIALS trial_result · 2024-07-18Clinical Trial Update: A COMbined progRamme of Exercise and Dietary ADvice in mEn With Castrate Resistant Prostate Cancer [NA]
This clinical trial update reports the completion of a study examining a combined exercise and dietary advice program for men with castratio…
-
CLINICAL_TRIALS research · 2024-07-18Clinical Trial Update: Reconstitution of a Human Immune System in a Patient Derived Xenograft (PDX) Model of Genitourinary (GU) Cancers
Clinical trial update on reconstituting a human immune system in a patient-derived xenograft model of genitourinary cancers; the study statu…
-
CLINICAL_TRIALS research · 2024-07-18Clinical Trial Update: PERIOPERATIVE MYOCARDIAL DAMAGE IN ROBOT-ASSISTED SURGERY
A clinical trial update examining perioperative myocardial damage in patients undergoing robot-assisted laparoscopic radical prostatectomy f…
-
CLINICAL_TRIALS trial_result · 2024-07-17Clinical Trial Update: The Application Value of Prostate Specific Membrane Antigen PET/CT in Biopsy Free of PSA Grey Area Prostate Cancer
A completed trial evaluating the usefulness of PSMA PET/CT imaging in biopsy-free, PSA grey-area prostate cancer.
-
CLINICAL_TRIALS research · 2024-07-16Clinical Trial Update: FUS-TB VS COG-TB in Small Lesions of Prostate Cancer [NA]
A clinical trial update comparing FUS-TB and COG-TB for small lesions in prostate cancer; the study is not yet recruiting.
-
CLINICAL_TRIALS research · 2024-07-15Clinical Trial Update: Correlation Between PSA Levels and F-18 PSMA PET/CT Findings in Prostate Cancer Patient
A clinical trial update examining the correlation between PSA levels and F-18 PSMA PET/CT findings in patients with prostate cancer.
-
CLINICAL_TRIALS research · 2024-07-12Clinical Trial Update: Curcumin and Piperine in Patients on Surveillance for Monoclonal Gammopathy, Smoldering Myeloma or Prostate Cancer [Phase 2]
Phase 2 clinical trial evaluating curcumin and piperine in patients under surveillance for monoclonal gammopathy, smoldering multiple myelom…
-
CLINICAL_TRIALS research · 2024-07-10Clinical Trial Update: 68Ga-PSMA PET/MRI in Conjunction With mpMRI for Evaluating Prospective Prostate Cancer Risk
This clinical trial evaluates 68Ga-PSMA PET/MRI in conjunction with mpMRI to assess prospective prostate cancer risk. The study is currently…